Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-07
DOI
10.1038/s41591-022-02162-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
- (2022) Hongjie Xia et al. Cell Host & Microbe
- Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
- (2022) Jing Zou et al. Nature Communications
- Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
- (2022) Yannic C. Bartsch et al. Science Translational Medicine
- Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 + T-Cell Epitopes Identified in COVID-19 Convalescent Individuals
- (2022) Andrew D. Redd et al. mBio
- Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
- (2022) Yang Liu et al. Cell Reports
- Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
- (2022) Chaitanya Kurhade et al. Nature Communications
- Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
- (2022) Bryan A. Johnson et al. PLoS Pathogens
- Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
- (2022) Chaitanya Kurhade et al. Emerging Microbes & Infections
- Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
- (2022) Fanchong Jian et al. LANCET INFECTIOUS DISEASES
- Covid-19 Vaccines — Immunity, Variants, Boosters
- (2022) Dan H. Barouch NEW ENGLAND JOURNAL OF MEDICINE
- Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark
- (2022) Frederik Plesner Lyngse et al. Nature Communications
- Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine
- (2022) Xuping Xie et al. Cell Reports
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
- (2022) Ruth Link-Gelles et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Engineering SARS-CoV-2 using a reverse genetic system
- (2021) Xuping Xie et al. Nature Protocols
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
- (2021) Alba Grifoni et al. Cell Host & Microbe
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
- (2021) Jianying Liu et al. NATURE
- The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
- (2021) Yang Liu et al. NATURE
- An Infectious cDNA Clone of SARS-CoV-2
- (2020) Xuping Xie et al. Cell Host & Microbe
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
- (2020) Antonio E. Muruato et al. Nature Communications
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now